Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: A multicentric, randomized trial

Stroke

Volumn 45, Issue 12, 2014, Pages 3618-3624

  Prasad, Kameshwar ^a   Sharma, Alka ^b   Garg, Ajay ^a   Mohanty, Sujata ^a   Bhatnagar, Shinjini ^a   Johri, Sharat ^c   Singh, Kunwar Karni ^c   Nair, Velu ^c   Sarkar, Ravi Shankar ^d   Gorthi, Sankar Prasad ^d   Hassan, Kaukab Maqbool ^d   Prabhakar, Sudesh ^e   Marwaha, Neelam ^e   Khandelwal, Niranjan ^e   Misra, Usha Kant ^f   Kalita, Jayantee ^f   Nityanand, Soniya ^f  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DEPARTMENT OF BIOTECHNOLOGY   (India)

^c ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^d ARMED FORCES MEDICAL COLLEGE   (India)

^e POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^f SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adult stem cells; Bone marrow cells; Cell and tissue based therapy; Cerebral infarction; Randomized controlled trial; Stem cell transplantation; Stroke

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BARTHEL INDEX; BONE MARROW BIOPSY; BONE MARROW DERIVED MONONUCLEAR CELL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; EPILEPTIC DISCHARGE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STEM CELL TRANSPLANTATION; SUBACUTE ISCHEMIC STROKE; THERAPY EFFECT; TREATMENT OUTCOME; AGED; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONVALESCENCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; STROKE;

AGED; BONE MARROW TRANSPLANTATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; STROKE;

EID: 84922481129     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007028     Document Type: Article

References (17)

1. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
2. Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, et al; IST-3 Collaborative Group. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke. 2014;45:1000-1006.
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:948-954.
4. Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr, Aronowski J, et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab. 2010;30:140-149.
5. Kamiya N, Ueda M, Igarashi H, Nishiyama Y, Suda S, Inaba T, et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 2008;83:433-437.
6. Giraldi-Guimardes A, Rezende-Lima M, Bruno FP, Mendez-Otero R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 2009;1266:108-120.
7. Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004;1007:1-9.
8. Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70:59-69.
9. Prasad K, Mohanty S, Bhatia R, Srivastava MV, Garg A, Srivastava A, et al. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian J Med Res. 2012;136:221-228.
10. Tour2India4health: Medi Tours and Health Tourism Services Web site. http://www.tour2india4health.com/Stem-Cell-Therapy-in-India.html. Accessed January 15, 2014.
11. Prasad K, Kaul S, Padma MV, Gorthi SP, Khurana D, Bakshi A. Stroke management. Ann Indian Acad Neurol. 2011;14(suppl 1):S82-S96.
12. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874-882.
13. Browner WS, Newman TB, Hully SB. Estimating sample size and power: applications and examples. In: Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB, eds. Designing Clinical Research. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:84.
14. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab. 2007;27:6-13.
15. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199-1209.
16. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003;73:296-307.
17. Yang B, Migliati E, Parsha K, Schaar K, Xi X, Aronowski J, et al. Intraarterial delivery is not superior to intravenous delivery of autologous bone |marrow mononuclear cells in acute ischemic stroke. Stroke. 2013;44 :3463-3472.